Further reading on prior authorization
Here are 5 excellent recent articles from Medical Economics on the topic of prior authorization:
Prior authorization remains one of the top pain points in health care, consuming hours of physician and staff time each week and delaying care for countless patients. This Medical Economics FAQ unpacks the most common questions physicians ask about prior authorization, its real costs, and what reforms may be on the horizon.
For physicians, few administrative tasks provoke as much frustration as prior authorization. What was once a narrow utilization tool has become a dominant source of paperwork, delays, and patient dissatisfaction. Surveys from
In this FAQ, Medical Economics answers some of the most frequently searched and hot-button questions about prior authorization, from why payers require it to how practices can mitigate its impact on both patients and their bottom line.
Prior authorization is a utilization-management process that requires physicians to obtain payer approval before providing certain tests, medications, or procedures. Insurers say it ensures services are medically necessary and cost-effective. The
While intended to prevent overuse of low-value care, it has expanded dramatically across specialties. For physicians, that means added administrative steps before care can proceed — and for patients, it can mean waiting days or weeks for coverage approval, according to the
Many physicians consider prior authorizations to be one of the top business and administrative challenges they face on a daily basis.
Publicly available data tells the story on prior authorization too:
Those hours translate into lost revenue and productivity. An analysis from
Here are 5 excellent recent articles from Medical Economics on the topic of prior authorization:
Common pain points include:
Delays and denials don’t just inconvenience patients — they can alter the course of treatment.
According to a
Physicians also note that payers’ clinical criteria often lag behind evidence-based medicine. In specialties such as oncology and behavioral health, those delays can be devastating. As Medical Economics previously reported in “How prior authorization hurts patient care”, deferred treatments frequently increase downstream costs as diseases progress untreated.
From the patient’s perspective, prior authorization can be confusing, stressful, and even dangerous.
Multiple studies have found that patients who faced repeated administrative barriers were less likely to adhere to treatment and more likely to lose confidence in their health system, and even their physician.
Effective management requires both workflow redesign and technology adoption:
Momentum for reform is building at both federal and state levels.
CMS finalized rules in 2024 that require faster electronic response times and more transparency from insurers. Meanwhile, state legislatures are passing laws that mandate uniform PA forms, set time limits for decisions, or require automatic renewals for chronic conditions, according to an
Several large insurers, including UnitedHealthcare and Cigna, have pledged to simplify or eliminate PA for certain services. Professional organizations such as the AMA, AAFP, and MGMA continue to advocate for comprehensive federal legislation that standardizes and automates the process nationwide.
Still, the administrative burden won’t vanish overnight. Practices that proactively optimize their workflows and adopt ePA technology will be best positioned as reforms take hold.
AI could significantly reduce the administrative burden of prior authorization, but experts say it’s no silver bullet.
AI-powered tools are increasingly being integrated into electronic health records (EHRs) and payer portals to automate repetitive tasks such as verifying coverage, identifying whether a service requires authorization, and compiling the correct documentation. These systems can pre-populate forms, flag missing clinical data, and even predict whether a request will be approved, according to a
Companies including Optum, Epic, and several revenue-cycle vendors are already deploying AI models to streamline decision making and speed up approvals. A 2024 report from CMS encouraged the adoption of electronic prior authorization (ePA) tools that incorporate machine learning to standardize data exchange and reduce manual reviews.
However, physicians remain cautious. The
The most likely near-term benefit, experts say, is efficiency. AI can shorten turnaround times, reduce staff workload, and flag denials for appeal faster. Over time, if regulators and payers standardize how AI tools exchange data, the technology could help restore the balance between cost control and timely patient care.
As Medical Economics noted in its feature
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.